Black Rock Inc. Repligen Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Repligen Corp stock. As of the latest transaction made, Black Rock Inc. holds 7,568,457 shares of RGEN stock, worth $1.2 Billion. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,568,457
Previous 7,773,131
2.63%
Holding current value
$1.2 Billion
Previous $1.43 Billion
33.26%
% of portfolio
0.02%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding RGEN
# of Institutions
481Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.13 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$811 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$269 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$245 Million1.48% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.36MShares$217 Million0.62% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.82B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....